ConductScience.org, home

Paper10697522

De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line.

Asada N and 2 others. Anticancer Res, 1999. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line. Papers, record 10697522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10697522

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line.
PubMed
Journal
Anticancer Res
PubMed
Year
1999
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Asada NN
2Tsuchiya HH
3Tomita KK

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CisplatinMajor topic
Gene DeletionMajor topic
Genes, p53Major topic
OsteosarcomaMajor topic
Base Sequence
Chromosomes, Human, Pair 17
DNA Primers
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Humans
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
38807682Lymph node myeloid sarcoma with TP53‑associated myelodysplastic syndrome: A case report.Oncol Lett2024https://conductscience.org/library/papers/38807682PubMed
35806218The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer.Int J Mol Sci2022https://conductscience.org/library/papers/35806218PubMed
34608255Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.Sci Rep2021https://conductscience.org/library/papers/34608255PubMed
33567616Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.Cancers (Basel)2021https://conductscience.org/library/papers/33567616PubMed
32961800Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.Int J Mol Sci2020https://conductscience.org/library/papers/32961800PubMed
32854207Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/32854207PubMed
31322224Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin.Mol Med Rep2019https://conductscience.org/library/papers/31322224PubMed
31276706TP53 in bone and soft tissue sarcomas.Pharmacol Ther2019https://conductscience.org/library/papers/31276706PubMed
29881292Emerging role of long non-coding RNAs in cisplatin resistance.Onco Targets Ther2018https://conductscience.org/library/papers/29881292PubMed
29535628Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine.Front Pharmacol2018https://conductscience.org/library/papers/29535628PubMed
28103585Long non-coding RNAs in osteosarcoma.Oncotarget2017https://conductscience.org/library/papers/28103585PubMed
26464619Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26464619PubMed
24765137Molecular mechanisms of chemoresistance in osteosarcoma (Review).Oncol Lett2014https://conductscience.org/library/papers/24765137PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10697522

GET https://conductscience.org/api/papers/v1/10697522/authors